Clinical Trial Update: Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss. [Phase 2]

View source ↗

Summary

The document describes a planned Phase 2 trial to evaluate the efficacy, safety, and pharmacokinetics of the compound 20E in obesity patients who are starting t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Wasting
• Obesity

Drugs mentioned

• 20E
• semaglutide (semaglutide)

Snippet

Sponsor: Biophytis | Conditions: Muscle Wasting, Obesity & Overweight | Phase 2 | Status: NOT_YET_RECRUITING